Pharmacoepidemiology | Aims and Scope Update

Scope (new version):

Scope (old version):

Pharmacoepidemiology welcomes manuscripts covering a broad range of areas including, but not limited to, the following:

• Designs, analyses, results, and interpretations of studies on drugs, biologics, or medical devices;
• Molecular pharmacoepidemiology;
• The methodology of pharmacoepidemiology;
• Pharmacovigilance/preventative pharmacovigilance/ecopharmacovigilance;
• Patient safety;
• Pharmacoepidemiology studies in targeted populations and settings;
• Patterns of drug utilization;
• Patterns of drug prescription, appropriateness of prescriptions, overprescription;
• Polypharmacology;
• Randomized control trials on drugs;
• Systematic review or meta-analysis related to drugs;
• Post-marketing surveillance;
• Pharmacoeconomics;
• The formulation and interpretation of regulatory guidelines;
• Studies on the benefits/safety/effectiveness of pharmaceuticals, biologics, or medical devices;
• Harm/benefit assessments in drug therapy;
• The evaluation of risk management plans on pharmaceuticals, biologics, and medical devices.

Pharmacoepidemiology welcomes manuscripts covering a broad range of areas including, but not limited to:

• designs, analyses, results, and interpretations of studies on drugs, biologics, or medical devices;
• molecular pharmacoepidemiology;
• the methodology of pharmacoepidemiology;
• pharmacovigilance;
• patient safety;
• patterns of drug utilization;
• post-marketing surveillance;
• pharmacoeconomics;
• the formulation and interpretation of regulatory guidelines;
• studies on the benefits/safety/effectiveness of pharmaceuticals, biologics, or medical devices;
• harm/benefit assessments in drug therapy;
• the evaluation of risk management plans on pharmaceuticals, biologics and medical devices.